Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the treatment of metabolic disorders. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://mariahmlls437915.aioblogs.com/91658658/retaglutide-a-promising-glp-1-receptor-agonist